Peroxisome proliferator-activated receptor-γ ligand reduced tumor necrosis factor-α-induced interleukin-8 production and growth in endometriotic stromal cells
article
OA: closed
CC0
⤵ 37 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
PPAR-γ ligands decreased TNF-α-induced IL-8 production and growth in endometriotic stromal cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (26)
- Advances in the management of endometriosis: an update for clinicians via openalex
- Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid via openalex
- Effect of Peroxisome Proliferator—Activated Receptor-γ Agonist Rosiglitazone on the Induction of Endometriosis in an Experimental Rat Model via openalex
- Efficacy and safety of nafarelin in the treatment of endometriosis via openalex
- Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis via openalex
- Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex
- Nuclear Peroxisome Proliferator-Activated Receptors α and γ Have Opposing Effects on Monocyte Chemotaxis in Endometriosis via openalex
- Pathogenetic Significance of Increased Levels of Interleukin-8 in the Peritoneal Fluid of Patients with Endometriosis via openalex
- Peroxisome proliferator-activated receptor-γ ligand inhibition of RANTES production by human endometriotic stromal cells is mediated through an upstream promoter element via openalex
- Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1 via openalex
- Role of cytokines in endometriosis via openalex
- Tumor Necrosis Factor-α-Induced Interleukin-8 (IL-8) Expression in Endometriotic Stromal Cells, Probably through Nuclear Factor-κB Activation: Gonadotropin-Releasing Hormone Agonist Treatment Reduced IL-8 Expression via openalex
- W6661376251 via openalex
- W1965583590 via openalex
- W6672127118 via openalex
- W1969161886 via openalex
- W1974618081 via openalex
- W1996634393 via openalex
- W2003115027 via openalex
- W2005051338 via openalex
- W2042642675 via openalex
- W2059895383 via openalex
- W2080393461 via openalex
- W2143715300 via openalex
- W2144829836 via openalex
- W2335925695 via openalex
Cited by (37)
- Correlation between lipid metabolism and endometriosis: a meta-analysis 2025
- The role of peroxisome proliferator-activated receptors in endometriosis 2024
- High intensity interval training is superior to moderate intensity continuous training in enhancing the anti-inflammatory and apoptotic effect of pentoxifylline in the rat model of endometriosis 2023
- TNFα-Induced Altered miRNA Expression Links to NF-κB Signaling Pathway in Endometriosis 2023
- Promotion of BST2 expression by the transcription factor IRF6 affects the progression of endometriosis 2023
- Identification of Potential Differentially Methylated Gene-Related Biomarkers in Endometriosis 2022
- Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α) as a Regulator of the Angiogenic Profile of Endometriotic Lesions 2022
- An Update on the Multifaceted Role of NF-kappaB in Endometriosis 2022
- Novel therapeutic strategy: antiinflammatory reagents 2021
- Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies† 2021
- The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights 2019
- From pathogenesis to clinical practice: Emerging medical treatments for endometriosis 2018
- Low-dose SKA Progesterone and Interleukin-10 modulate the inflammatory pathway in endometriotic cell lines 2017
- An Update on Pathophysiology and Medical Management of Endometriosis 2016
- Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics 2016
- Pathogenesis of Endometriosis: Roles of Retinoids and Inflammatory Pathways 2015
- Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor- by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions 2014
- Medical Treatments for Endometriosis-Associated Pelvic Pain 2014
- Regression of experimental endometriotic implants in a rat model with the angiotensin <scp>II</scp> receptor blocker losartan 2014
- Inflammation and Cytokines in Endometriosis 2014
- Effect of a dienogest for an experimental three-dimensional endometrial culture model for endometriosis 2013
- Endometriosis 2013
- Metformin as a new therapy for endometriosis, its effects on both clinical picture and cytokines profile 2012
- The Epigenetics of Endometriosis 2012
- Histone deacetylase inhibitors as therapeutics for endometriosis 2012
- Regulación del crecimiento del tejido endometrial en respuesta a nuevas alternativas terapéuticas propuestas para tratar la endometriosis 2012
- Pathogenesis: Epigenetics 2011
- Peroxisome proliferating activating receptor gamma–independent attenuation of interleukin 6 and interleukin 8 secretion from primary endometrial stromal cells by thiazolidinediones 2011
- Physiologic activation of nuclear factor kappa-B in the endometrium during the menstrual cycle is altered in endometriosis patients 2011
- Constitutive and Tumor Necrosis Factor-Alpha-Stimulated Activation of Nuclear Factor-KappaB in Immortalized Endometriotic Cells and Their Suppression by Trichostatin A 2010
- Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis 2010
- Involvement of the nuclear factor-kB pathway in the pathogenesis of endometriosis 2010
- A Botanical Extract from Channel Flow Inhibits Cell Proliferation, Induces Apoptosis, and Suppresses CCL5 in Human Endometriotic Stromal Cells1 2009
- Endometriosis 2009
- Thiazolidinediones as Therapy for Endometriosis: A Case Series 2009
- PPAR-γ expression in peritoneal endometriotic lesions correlates with pain experienced by patients 2009
- Emerging drugs for endometriosis 2008
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:14:54.534439+00:00
License: CC0
· commercial use OK